Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment

2021198 citationsJournal Articlehybrid Open Access

Authors

Thomas Stöhr · Paion (Germany)

Pieter Colin · University of Groningen

Joachim Ossig · Paion (Germany)

Marija Pesic · Paion (Germany)

Keith M. Borkett

Peter Winkle · Anaheim Clinical Trials

Michel Struys · University Medical Center Groningen

Abstract

Hepatic impairment trial: ClinicalTrials.gov, NCT01790607 (https://clinicaltrials.gov/ct2/show/NCT01790607). Renal impairment trial: EudraCT Number: 2014-004575-23.

Topics & Keywords

Anesthesia and Sedative Agents Epilepsy research and treatment EEG and Brain-Computer Interfaces

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Anaesthesia

Volume 127, Issue 3, pp. 415-423

DOI: 10.1016/j.bja.2021.05.027

Field-Weighted Citation Impact: 31.72